Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...

Demis Hassabis — co-founder and CEO of Google DeepMind, and one of the world's top AI pioneers — says the technology's coming ...

Google DeepMind co-founder & CEO Demis Hassabis speaks with columnist Bina Venkataraman about AI’s role in enabling scientific breakthroughs, why human-level intelligence is an “important ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...

but Demis Hassabis did. And win it, he did. In October 2024, the British co-founder and chief executive officer of Google DeepMind received the Nobel Prize for Chemistry, sharing it with his ...

Researchers are identifying current and future dangers within AI models away from the conflicts of interest they’d face in ...

AI has already disrupted fields like coding, investment banking and law, but it looks to be poised to change yet another ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. Isomorphic is ...

"Given that the companies behind the large language models have released them without sort of putting guardrails around their ...